]>
IRCT20190618043935N1 IRCT 2020-05-23 The university of Sistan and Baluchestan Effect of Low-Repetition and Light-Load Power Training on Post menopausal Women Effect of 6 Weeks of Low-Repetition and Light-Load Power Training on Serum Levels of b-ALP and CTX in Postmenopausal Women 2019-09-23 anticipated 30 Complete https://irct.ir/trial/47373 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Prevention, Randomization description: Randomization method: Simple Randomization, Randomization unit: individually, Randomization tool: Table of Random Numbers, How to make Randomization sequence: From the top to the end of list, Allocation Concealment: A third person allocate numbers to the participants then using table of Random Numbers another person select the numbers with closed eyes. N/A Condition 1: Menopause. Condition 2: Osteoporosis. Intervention 1: Intervention group: Power trainings will be performed for 6 weeks, 5 sessions per week, 8 sets, 3 repetitions and 15 seconds rest between sets, including 5 activities (Scot, forward lounge, side lounge, cuff rise and toe rise) and to produce power in mentioned activities, the concentric phase should be done so fast in correct body straight posture. After 10 minutes of warm up the training starts and finished after 10 minutes of cool down. Intervention 2: Control group: No intervention has received. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information.
public Shila Nayebifar
No. 18, Danesh Ave., Daneshjo Blvd
Zahedan Iran (Islamic Republic of) 9897567 +98 54 3113 6813 shila_nayebifar@ped.usb.ac.ir The University of Sistan and Baluchestan scientific Shila Nayebifar
No. 18, Danesh Ave., Daneshjo Blvd.
Zahedan Iran (Islamic Republic of) 98976556 +98 54 3113 6813 shila_nayebifar@ped.usb.ac.ir The University of Sistan and Baluchestan Iran (Islamic Republic of) Having no exercise background At least two years should be passed from their menopause time. Not having any special problems such as cardiovascular, metabolic, kidney, orthopedic diseases. No smoking. 55 years 65 years Female The exclusion criteria include applying any medication and food supplements, diet therapy. Being in amenorrhea state Prevention Prevention Intervention group: Power trainings will be performed for 6 weeks, 5 sessions per week, 8 sets, 3 repetitions and 15 seconds rest between sets, including 5 activities (Scot, forward lounge, side lounge, cuff rise and toe rise) and to produce power in mentioned activities, the concentric phase should be done so fast in correct body straight posture. After 10 minutes of warm up the training starts and finished after 10 minutes of cool down. Control group: No intervention has received. Serum levels of Osteocalcin. Timepoint: At the beginning of program (before starting intervention) and at the end of program (48 hours after last training session). Method of measurement: Measurement of serum Osteocalcin will be assessed using a kit (Zell Bio, Germany) with a sensitivity of 0.026 ng/ml. Serum levels of Paratormone. Timepoint: At the beginning of program (before starting intervention) and at the end of program (48 hours after last training session). Method of measurement: Paratormon will be assessed using a kit (Zell Bio, Germany) with a sensitivity of 1.56 ng/ml. Serum levels of Sclerostin. Timepoint: At the beginning of program (before starting intervention) and at the end of program (48 hours after last training session). Method of measurement: Sclerostin will be assessed using Hangzhou Stabiopharm kit (China), with a sensitivity of 0.26 ng/ml and ELISA method. Serum levels of Bone Alkalin Phosphatase. Timepoint: At the beginning of program (before starting intervention) and at the end of program (48 hours after last training session). Method of measurement: Bone Alkalin Phosphatase will be assessed using Hangzhou Stabiopharm kit (China), with a sensitivity of 0.52 pmol/l and ELISA method. Serum levels of C- terminal telopeptides of type I collagen. Timepoint: At the beginning of program (before starting intervention) and at the end of program (48 hours after last training session). Method of measurement: C- terminal telopeptides of type I collagen will be assessed using Hangzhou Stabiopharm kit (China), with a sensitivity of 0.01ng/ml and ELISA method. University of Sistan and Baluchestan Approved 2019-10-22 Ethics committee of Sistan and Baluchestan University Daneshgah Blvd Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)